JITREA, created in 2012 (Belgium), from 11 sister brands and 2214 competing brands. The JITREA brand is owned by ThromboGenics, a company listed in Bruxelles. Its International Securities Identification Number (ISIN) is BE0003846632. JITREA is part of the Biotechnology activity sector.

JITREA is a brand of ThromboGenics (OXUR) Share price

International deposit : 2012 Business sector Biotechnology

Share price and profitability of the share ThromboGenics (JITREA)

Buy ThromboGenics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 0.00

Portfolio valuation
ThromboGenics (JITREA) over 5 years* EUR 0.00

Stock market history ThromboGenics (JITREA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ThromboGenics

THROMBOGENICS
THROMBOGENICS
See more brands of ThromboGenics

Rival brands
JITREA

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS